Breast Cancer
Commentary
Mammography breast density reporting: What it means for clinicians
Should this be something that we talk to patients about, utilizing shared decision-making to decide about whether follow-up testing is necessary...
From the Journals
Do AI chatbots give reliable answers on cancer? Yes and no
“The chatbot was most likely to mix in incorrect recommendations among correct ones, an error difficult even for experts to detect.”
From the Journals
No link between most cancers and depression/anxiety: Study
The findings “may help health professionals to alleviate feelings of guilt and self-blame in patients with cancer who attribute their diagnosis to...
Latest News
Breast cancer: Hope in sight for improved tamoxifen therapy?
Eventually, the idea is to combine treatment with antiestrogens with a medicinal product that promotes localization of PRMT5 in the nucleus to...
From the Journals
Cancer rates rise among people under age 50
“If we don’t understand what’s causing this risk and we can’t do something to change it, we’re afraid that as time goes on, it’s going to become a...
From the Journals
Alcohol consumption may not influence breast cancer prognosis, study
The findings could help in developing specific guidelines related to the prevention of breast cancer recurrence and death in survivors.
From the Journals
Older women risk overdiagnosis with mammograms: Study
Overdiagnosis carries the risks of complications from overtreatment, plus financial and emotional hardships.
From the Journals
Scalp cooling for chemo hair loss strikes out with patients
“The efficacy and tolerability of [scalp cooling] applied in a clinical routine setting ... appeared to be limited.”
Feature
How useful are circulating tumor cells for early diagnosis?
Their link with metastases, and thus with aggressive tumors, gives them an advantage over other (noninvasive or minimally invasive) biomarkers in...
Commentary
Considering the true costs of clinical trials
There are many subtle and some egregious ways that participating in clinical trials can result in increased costs.
From the Journals
PPIs may curb benefits of palbociclib in breast cancer
“The findings suggest that taking PPIs with palbociclib may interrupt the full therapeutic benefits of palbociclib,” the authors conclude.